On the record · Company

Nivagen Pharmaceuticals

Research depth

Ownership researched

Ownership research and public source records are available.

Record updated Oct. 2, 2026

Current ownership

Recorded current owner

PAI Pharma

Control interest · Since Jan. 6, 2026

These are database records. Death by PE has not published a reviewed current-owner finding for them.

Ownership and transaction history

Chronology from recorded ownership periods, transactions and reviewed outcome events. Event order does not imply causation.

Jan. 6, 2026

Acquisition completedR1R2

Acquirer: PAI Pharma · Sponsor: Olympus Partners

Recorded history

Jan. 6, 2026

Ownership period beganR1R2

Owner: PAI Pharma

Recorded history

Sources and evidence

Recorded transaction sources

These support a recorded transaction row. They have not passed the separate evidence-review process.

  1. R1
    PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Ready-To-Use Product Offering in the Hospital Market | PAI Pharma

    PAI Pharma · Company announcement · Retrieved Oct. 2, 2026

    Supports: Recorded ownership period; Recorded transaction

  2. R2
    PAI Pharma Acquires Nivagen Pharmaceuticals to Expand Sterile Injectable and RTU Hospital Offerings – Welcome to Nivagen Pharmaceuticals

    Nivagen Pharmaceuticals · Company announcement · Retrieved Oct. 2, 2026

    Supports: Recorded ownership period; Recorded transaction

What we do not know

These are gaps in the public record, not findings about the organization.

  • The organization's operating status has not been researched.
  • No current public ownership assessment has been published.

Help improve this record

Firsthand experience, public sources and corrections can help close the gaps above.